27.81 USD
+1.14 (+4.27%)
27.65 USD
-0.16 (-0.58%)
ChartMill assigns a Buy % Consensus number of 81% to CLDX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 54.21. This target is 94.91% above the current price.
CLDX was analyzed by 22 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about CLDX.
In the previous month the buy percentage consensus was at a similar level.
CLDX was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-11 | Barclays | Maintains | Underweight -> Underweight |
| 2025-10-21 | Mizuho | Initiate | Outperform |
| 2025-10-13 | Barclays | Initiate | Underweight |
| 2025-09-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-20 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-20 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-20 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-09 | UBS | Maintains | Buy -> Buy |
| 2025-05-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-05-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-28 | Canaccord Genuity | Initiate | Buy |
| 2025-03-20 | Morgan Stanley | Initiate | Overweight |
| 2025-03-03 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-13 | UBS | Initiate | Buy |
| 2025-01-29 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-01-02 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-12-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-07 | Citigroup | Initiate | Buy |
| 2024-09-30 | Goldman Sachs | Initiate | Neutral |
CELLDEX THERAPEUTICS INC / CLDX FAQ
What do analysts expect the price target to be for CELLDEX THERAPEUTICS INC (CLDX)?
22 analysts have analysed CLDX and the average price target is 54.21 USD. This implies a price increase of 94.91% is expected in the next year compared to the current price of 27.81.
What is the consensus rating for CLDX stock?
The consensus rating for CELLDEX THERAPEUTICS INC (CLDX) is 80.9091 / 100 . This indicates that analysts generally have a positive outlook on the stock.